HK1202260A1 - 宿醉的預防劑及/或治療劑 - Google Patents
宿醉的預防劑及/或治療劑Info
- Publication number
- HK1202260A1 HK1202260A1 HK15102804.5A HK15102804A HK1202260A1 HK 1202260 A1 HK1202260 A1 HK 1202260A1 HK 15102804 A HK15102804 A HK 15102804A HK 1202260 A1 HK1202260 A1 HK 1202260A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- veisalgia
- treating
- preventing
- agent
- treating veisalgia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011267841 | 2011-12-07 | ||
PCT/JP2012/081080 WO2013084816A1 (ja) | 2011-12-07 | 2012-11-30 | 二日酔いの予防剤及び/又は治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202260A1 true HK1202260A1 (zh) | 2015-09-25 |
Family
ID=48574184
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18115886.5A HK1256803A1 (zh) | 2011-12-07 | 2015-03-18 | 宿醉的預防劑及/或治療劑 |
HK15102804.5A HK1202260A1 (zh) | 2011-12-07 | 2015-03-18 | 宿醉的預防劑及/或治療劑 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18115886.5A HK1256803A1 (zh) | 2011-12-07 | 2015-03-18 | 宿醉的預防劑及/或治療劑 |
Country Status (8)
Country | Link |
---|---|
US (2) | US20140343140A1 (zh) |
EP (1) | EP2789336B1 (zh) |
JP (1) | JP5809291B2 (zh) |
CN (2) | CN104144686A (zh) |
HK (2) | HK1256803A1 (zh) |
RU (1) | RU2593365C2 (zh) |
TW (1) | TWI571455B (zh) |
WO (1) | WO2013084816A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10449353B2 (en) | 2016-04-28 | 2019-10-22 | Medtronic, Inc. | Electrode assemblies, methods, and components thereof for implantable medical electrical leads |
JPWO2018043240A1 (ja) | 2016-09-02 | 2019-06-24 | Sbiファーマ株式会社 | 5−アミノレブリン酸類を含む水性製剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4966665B2 (ja) * | 2003-11-19 | 2012-07-04 | オメガ バイオ−ファーマ (アイ.ピー.1) リミテッド | アルコール代謝を改善し、二日酔いの影響を軽減するための材料と方法 |
CA2752569C (en) * | 2004-09-02 | 2014-09-16 | Cosmo Oil Co., Ltd. | .delta.-amino acid as an exercise function-improving agent |
JP2007192659A (ja) * | 2006-01-19 | 2007-08-02 | Sogo Ikagaku Kenkyusho:Kk | 疲労度評価方法およびその利用 |
CA2722578C (en) * | 2008-05-14 | 2014-02-11 | Sbi Alapromo Co., Ltd. | Use of .delta.-amino levulinic acid to treat male infertility |
JP2009143939A (ja) * | 2009-01-27 | 2009-07-02 | Tsujido Chemical Corp | 治療剤 |
WO2011161220A1 (en) * | 2010-06-23 | 2011-12-29 | Photocure Asa | Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent |
CN103747784B (zh) * | 2011-08-12 | 2018-01-30 | 思佰益药业股份有限公司 | 败血症的预防剂和/或治疗剂 |
JP5907357B2 (ja) * | 2011-10-12 | 2016-04-26 | Sbiファーマ株式会社 | 移植臓器生着促進剤 |
-
2012
- 2012-11-29 TW TW101144773A patent/TWI571455B/zh active
- 2012-11-30 RU RU2014126564/15A patent/RU2593365C2/ru active
- 2012-11-30 WO PCT/JP2012/081080 patent/WO2013084816A1/ja active Application Filing
- 2012-11-30 US US14/361,187 patent/US20140343140A1/en not_active Abandoned
- 2012-11-30 CN CN201280059096.8A patent/CN104144686A/zh active Pending
- 2012-11-30 JP JP2013548209A patent/JP5809291B2/ja active Active
- 2012-11-30 CN CN201810612593.5A patent/CN108743574A/zh active Pending
- 2012-11-30 EP EP12854923.5A patent/EP2789336B1/en active Active
-
2015
- 2015-03-18 HK HK18115886.5A patent/HK1256803A1/zh unknown
- 2015-03-18 HK HK15102804.5A patent/HK1202260A1/zh unknown
- 2015-11-30 US US14/954,171 patent/US10022345B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108743574A (zh) | 2018-11-06 |
JPWO2013084816A1 (ja) | 2015-04-27 |
EP2789336A4 (en) | 2015-05-27 |
US10022345B2 (en) | 2018-07-17 |
CN104144686A (zh) | 2014-11-12 |
EP2789336B1 (en) | 2016-12-14 |
TWI571455B (zh) | 2017-02-21 |
RU2593365C2 (ru) | 2016-08-10 |
US20160081957A1 (en) | 2016-03-24 |
EP2789336A1 (en) | 2014-10-15 |
TW201323382A (zh) | 2013-06-16 |
JP5809291B2 (ja) | 2015-11-10 |
RU2014126564A (ru) | 2016-01-27 |
HK1256803A1 (zh) | 2019-10-04 |
WO2013084816A1 (ja) | 2013-06-13 |
US20140343140A1 (en) | 2014-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1214521A1 (zh) | 用於治療蛋白質病的組合物和方法 | |
AP3269A (en) | Methods and compounds for treating paramyxoviridaevirus infections | |
HK1202486A1 (zh) | 表面處理方法、表面處理劑及新型化合物 | |
HK1201475A1 (zh) | 治療疼痛的方法和組合物 | |
HK1204988A1 (zh) | 用於預防或治療眼科病狀的方法和組合物 | |
HK1251796A1 (zh) | 治療糖尿病的方法和組合物 | |
EP2755614A4 (en) | SYSTEMS AND METHOD FOR PROSTATE TREATMENT | |
IL227429A0 (en) | The components and methods of cancer treatment | |
EP2757887A4 (en) | PYRROLOPYRIDINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF HIV | |
EP2755482A4 (en) | COMPOSITIONS AND METHODS OF TREATING CANCER | |
PL2807323T3 (pl) | Kompozycja i sposób obróbki układów wodnych | |
HK1215170A1 (zh) | 治療精神分裂症的方法和組合物 | |
HK1209633A1 (zh) | 治療糖尿病的組合物和方法 | |
EP2544655A4 (en) | COMPOSITIONS AND METHODS FOR TREATING SKIN | |
EP2766009A4 (en) | METHOD AND COMPOSITIONS FOR SKIN TREATMENT | |
IL232648A0 (en) | Preparations and methods for treating glioma | |
GB201002083D0 (en) | Apparatus for improving and/or maintaining numerical ability | |
EP2688402A4 (en) | METHODS FOR THE TREATMENT OR PREVENTION OF UROLOGIC INFLAMMATION | |
IL229231A0 (en) | Preparations and methods for the treatment of cancer | |
HK1197583A1 (zh) | 預防和治療敗血症的方法 | |
EP2907897A4 (en) | SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD | |
HK1183766A1 (zh) | 用於治療瘀傷的組合物和方法 | |
EP2708223A4 (en) | COLORING AGENT AND USE THEREOF | |
EP2745838A4 (en) | PROPHYLACTIC AGENT AND / OR THERAPEUTIC AGENT FOR SEPTICEMIA | |
HK1202260A1 (zh) | 宿醉的預防劑及/或治療劑 |